Geode Capital Management’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.29M Buy
3,794,827
+435,389
+13% +$492K ﹤0.01% 2806
2025
Q1
$4.91M Buy
3,359,438
+126,820
+4% +$185K ﹤0.01% 2663
2024
Q4
$6.89M Buy
3,232,618
+5,514
+0.2% +$11.7K ﹤0.01% 2573
2024
Q3
$9.04M Buy
3,227,104
+407,070
+14% +$1.14M ﹤0.01% 2446
2024
Q2
$6.57M Buy
2,820,034
+448,700
+19% +$1.05M ﹤0.01% 2580
2024
Q1
$10.6M Buy
2,371,334
+36,139
+2% +$162K ﹤0.01% 2291
2023
Q4
$7.5M Buy
2,335,195
+263,842
+13% +$847K ﹤0.01% 2487
2023
Q3
$6.57M Buy
2,071,353
+243,571
+13% +$772K ﹤0.01% 2502
2023
Q2
$9.08M Buy
1,827,782
+78,538
+4% +$390K ﹤0.01% 2340
2023
Q1
$8.64M Buy
1,749,244
+42,784
+3% +$211K ﹤0.01% 2348
2022
Q4
$10.7M Buy
1,706,460
+77,793
+5% +$489K ﹤0.01% 2222
2022
Q3
$17.6M Buy
1,628,667
+160,061
+11% +$1.73M ﹤0.01% 1832
2022
Q2
$16.7M Buy
1,468,606
+207,355
+16% +$2.36M ﹤0.01% 1879
2022
Q1
$11.5M Sell
1,261,251
-117,652
-9% -$1.07M ﹤0.01% 2260
2021
Q4
$20.6M Buy
1,378,903
+118,850
+9% +$1.77M ﹤0.01% 1946
2021
Q3
$32.4M Buy
1,260,053
+31,972
+3% +$822K ﹤0.01% 1640
2021
Q2
$32M Buy
1,228,081
+155,250
+14% +$4.05M ﹤0.01% 1665
2021
Q1
$37.9M Buy
1,072,831
+83,925
+8% +$2.96M 0.01% 1447
2020
Q4
$25M Buy
988,906
+46,980
+5% +$1.19M ﹤0.01% 1582
2020
Q3
$35.5M Buy
941,926
+35,849
+4% +$1.35M 0.01% 1108
2020
Q2
$38.8M Buy
906,077
+170,840
+23% +$7.32M 0.01% 1033
2020
Q1
$14.3M Buy
735,237
+56,183
+8% +$1.09M ﹤0.01% 1514
2019
Q4
$17.6M Buy
679,054
+25,869
+4% +$672K ﹤0.01% 1645
2019
Q3
$17.8M Buy
653,185
+239,671
+58% +$6.53M ﹤0.01% 1562
2019
Q2
$11.1M Buy
413,514
+102,625
+33% +$2.76M ﹤0.01% 1875
2019
Q1
$8.99M Sell
310,889
-8,179
-3% -$236K ﹤0.01% 1971
2018
Q4
$8.59M Buy
+319,068
New +$8.59M ﹤0.01% 1872